Radiation therapy and immunotherapy: Growing pains

International Journal of Radiation Oncology Biology Physics

Volumn 91, Issue 2, 2015, Pages 252-254

  Golden, Encouse B ^a   Formenti, Silvia C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IPILIMUMAB; PROBASIN; SIPULEUCEL T; TUMOR ANTIGEN; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; TAXOID;

ANTIBODY TITER; BONE METASTASIS; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CELL DEATH; CLINICAL TRIAL (TOPIC); DISEASE COURSE; HUMAN; IMMUNOCOMPETENT CELL; LIVER METASTASIS; LUNG CANCER; MELANOMA; NONHUMAN; OVERALL SURVIVAL; PATIENT SELECTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REGULATORY T LYMPHOCYTE; REVIEW; SPINE METASTASIS; TUMOR IMMUNITY; MALE; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; HUMANS; MALE; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; TAXOIDS;

EID: 84922473329     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.09.018     Document Type: Editorial

References (13)

1. Kwon ED, Drake CG, Scher HI, et al. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol 2014;15:700-712.
2. Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: A paradigm shift. J Natl Cancer Inst 2013;105:256-265.
3. Golden EB, Frances D, Pellicciotta I, et al. Radiation fosters dosedependent and chemotherapy-induced immunogenic cell death. Oncoimmunology 2014;3:e28518.
4. Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 2012;366:925-931.
5. Golden EB, Demaria S, Schiff PB, et al. An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res 2013;1:365-372.
6. Demaria S, Kawashima N, Yang AM, et al. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res 2005;11:728-734.
7. Harris TJ, Hipkiss EL, Borzillary S, et al. Radiotherapy augments the immune response to prostate cancer in a time-dependent manner. Prostate 2008;68:1319-1329.
8. Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of shortversus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005;97:798-804.
9. Dewan MZ, Galloway AE, Kawashima N, et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res 2009;15:5379-5388.
10. Hiniker SM, Chen DS, Reddy S, et al. A systemic complete response of metastatic melanoma to local radiation and immunotherapy. Transl Oncol 2012;5:404-407.
11. Simpson TR, Li F, Montalvo-Ortiz W, et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. J Exp Med 2013;210:1695-1710.
12. Kantoff PW, Higano CS, Shore ND, et al. Sipuleucel-t immunotherapy for castration-resistant prostate cancer. N Engl J Med 2010;363:411-422.
13. Barker CA, Postow MA. Combinations of radiation therapy and immunotherapy for melanoma: A review of clinical outcomes. Int J Radiat Oncol Biol Phys 2014;88:986-997.